NDC 81033-032-01 - Mupirocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-032
- Requested NDC
- 81033-032-01
- Package NDCs from labels
- 81033-032-01, 81033-032-50, 81033-032-99
- Manufacturer
- Kesin Pharma Corporation
- Effective date
- 2025-05-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mupirocin Ointment - Kesin Pharma Corporation | Kesin Pharma Corporation | 2025-05-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-032-01 | Mupirocin | 1 g in 1 TUBE | OINTMENT | 1 | 7 | |
| 81033-032-50 | Mupirocin | 50 in 1 BOX | OINTMENT | 50 | 7 | |
| 81033-032-99 | Mupirocin | 100 in 1 BOX | OINTMENT | 100 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-032-01 | GM - Gram | 81033-032 | bee79b6e-6f9e-40d7-861f-6b07462600b9 | 1 | 2025-06-13 |
| 81033-032-50 | GM - Gram | 81033-032 | c06a73cb-4436-4d1a-a85d-c11b32f9f744 | 1 | 2025-06-13 |
| 81033-032-99 | GM - Gram | 81033-032 | 72584aad-1ebd-45d0-a738-c191d702f88f | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | G2M7P15E5P |
| dg health clearlax | POLYETHYLENE GLYCOL 3350 | Dolgencorp, LLC | 94280ce4-b2cf-451d-a660-b26ab1a2d3f0 | 2023-02-06 | Warnings | G2M7P15E5P |
| clearlax | POLYETHYLENE GLYCOL 3350 | H E B | 0b4b752d-045d-4ff0-8e50-5607d1a841a7 | 2023-01-26 | Warnings | G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 435db89c-1e32-4da5-b7d0-15e407162715 | 2023-01-24 | Warnings | G2M7P15E5P |
| Mupirocin | MUPIROCIN | Proficient Rx LP | d8766748-6b53-4673-a3ee-5cd8a4301647 | 2023-01-01 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| basic care clearlax | POLYETHYLENE GLYCOL 3350 | Amazon.com Services LLC | 21897170-0d5e-4326-bebf-10258e0aca82 | 2022-12-08 | Warnings | G2M7P15E5P |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | Geri-Care Pharmaceutical Corp | f4c7eb80-d8d5-406d-90d0-9d17914d71f2 | 2022-11-24 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Gericare Pharmaceuticals | 5d0d2c14-24e6-45b4-92f6-4eaf5da72cdd | 2022-10-28 | Warnings | G2M7P15E5P |
| Mupirocin | MUPIROCIN | Proficient Rx LP | cbb18010-f3b5-4ed7-8c03-c9203f0e360e | 2022-10-01 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Equate ClearLAX | POLYETHYLENE GLYCOL 3350 | WALMART INC. | c5c13378-3c08-415f-8ab4-8a18d6300ca8 | 2022-09-08 | Warnings | G2M7P15E5P |
| injoy constipation relief | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | b2414517-04bf-4f29-951e-b867855078c3 | 2022-08-19 | Warnings | G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 0858a914-4812-4e4d-82f8-ecf93d43ef3b | 2022-07-01 | Warnings | G2M7P15E5P |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 199d6173-3fad-49e4-88fe-bde7223ed4c3 | 2022-06-01 | Warnings | G2M7P15E5P |
| Mupirocin | MUPIROCIN | Teva Pharmaceuticals USA, Inc. | a543797a-2c1c-4ea3-bd6c-227a784f92d9 | 2022-05-01 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | Proficient Rx LP | 97f8d67d-c422-4a26-9394-24a5ec9719d9 | 2022-04-01 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Polyethylene Glycol | POLYETHYLENE GLYCOL | BluePoint Laboratories | c4cae70c-68da-0bbc-e053-2a95a90a395a | 2021-09-20 | Warnings | G2M7P15E5P |
| signature care clearlax | POLYETHYLENE GLYCOL 3350 | Safeway | 91d2e780-2aae-411c-b7b3-820302f0f63e | 2021-05-13 | Warnings | G2M7P15E5P |
| mupirocin | MUPIROCIN | Asclemed USA, Inc. | b2ff9c56-ca19-48ca-bd08-4b33edb13a08 | 2020-11-09 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| POLYETHYLENE GLYCOL 3350 NF | POLYETHYLENE GLYCOL 3350 | SUNRISE PHARMACEUTICAL, INC | ce5197a1-2677-4ffb-aef2-9221b28ebd23 | 2020-01-22 | Warnings | G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.